Under Pressure: Arugula Extract's Effect on Blood Pressure in Hypertensive Individuals

Brief summary (registry, in English)

The purpose of this randomized, single-blind, placebo-controlled, crossover study was to investigate the acute effects of arugula extract (AE) supplementation on blood pressure, endothelial function, and circulating nitric oxide (NO) metabolites in individuals with elevated to stage 1 hypertension. Hypertension is a major contributing factor to cardiovascular disease (CVD) and is commonly associated with endothelial dysfunction and impaired NO bioavailability. Dietary nitrate supplementation has demonstrated beneficial effects on cardiovascular health through the nitrate-nitrite-NO pathway. Although nitrate-rich supplements such as beetroot juice have been extensively investigated, limited research has examined the vascular effects of arugula extract in individuals with hypertension. Sixteen adults between the ages of 18 and 50 years with elevated to stage 1 hypertension participated in the study. Participants completed two experimental conditions in randomized order: 4,000 mg of arugula extract, providing approximately 400 mg of dietary nitrate, and 4,000 mg of psyllium husk placebo. Each condition was separated by a minimum 72-hour washout period to minimize potential carryover effects. During each experimental condition, participants underwent baseline cardiovascular and vascular assessments before consuming the assigned supplement. Systolic blood pressure, diastolic blood pressure, heart rate, and venous blood samples were collected at baseline and 1, 2, 3, and 24 hours following supplementation. Endothelial function was assessed through brachial artery flow-mediated dilation (FMD) at baseline, 3 hours, and 24 hours post-supplementation. Blood samples were analyzed to assess circulating nitrate, nitrite, and total NO metabolites. The primary objective was to determine whether acute arugula extract supplementation improved endothelial function and reduced blood pressure compared with placebo. Secondary objectives included evaluating changes in circulating NO metabolites. This investigation sought to determine the potential of arugula extract as a dietary nitrate intervention for improving vascular health in individuals with elevated blood pressure.

What you commit to

• Study type: Interventional
• Participants enrolled: 16
• From 11 Sept 2025 to the primary completion date, 14 Jul 2026
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.